Health­care, pharma, digi­tal / tech­no­logy, consu­mer, retail, indus­tri­als, B2B services

€ 25 m – € 500 m

Selec­ted Tran­sac­tions: (1) Sale of a majo­rity stake of FR L’Osteria SE to McWin Part­ners. (2) Acqui­si­tion of Arko­pharma SE by Derm­a­ph­arm from Montagu Private Equity LLP. (3) Merger of Vitafy Brands and EVP Group. (4) Acqui­si­tion of C3-Canna­bi­noid Compound Company GmbH by Derm­a­ph­arm from Canopy Growth Corpo­ra­tion. (5) Sale of a majo­rity owner­ship stake in Derma­zen­trum in an Owners Buy-out to Halder. (6) USD 40m private place­ment of Wells­ter Health­tech. (7) Sale of 75% of team­tech­nik Maschi­nen und Anla­gen to Dürr group. (8) Acqui­si­tion of Neur­ax­ph­arm by Perm­ira from Apax Part­ners. (9) Acqui­si­tion of Wind­Star Medi­cal GmbH by Oakley Capi­tal from ProSiebenSat.1 majo­rity-owned NuCom group.

Health­care, pharma, digi­tal / tech­no­logy, consu­mer, retail, indus­tri­als, B2B services

(1) Dives­ti­tures and acqui­si­ti­ons, (2) Manage­ment buy-outs (MBOs), Manage­ment buy-ins (MBIs) and lever­a­ged buy-outs (LBOs), (3) Mergers and joint ventures, (4) Public to Private / Public take-overs, (5) Private place­ments / Corpo­rate Finance.